Compare AIN & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIN | BCRX |
|---|---|---|
| Founded | 1895 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Textiles | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.1B |
| IPO Year | 1994 | 1995 |
| Metric | AIN | BCRX |
|---|---|---|
| Price | $53.56 | $8.21 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $60.25 | $20.82 |
| AVG Volume (30 Days) | 285.4K | ★ 4.1M |
| Earning Date | 06-01-2026 | 05-15-2026 |
| Dividend Yield | ★ 2.05% | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | N/A | ★ 1.21 |
| Revenue | ★ $1,054,132,000.00 | $25,186,000.00 |
| Revenue This Year | $2.89 | N/A |
| Revenue Next Year | N/A | $12.55 |
| P/E Ratio | ★ N/A | $6.93 |
| Revenue Growth | ★ 7.29 | N/A |
| 52 Week Low | $41.15 | $6.00 |
| 52 Week High | $75.16 | $11.31 |
| Indicator | AIN | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.55 | 57.26 |
| Support Level | $52.70 | $7.95 |
| Resistance Level | $53.88 | $8.68 |
| Average True Range (ATR) | 2.38 | 0.33 |
| MACD | -0.60 | -0.01 |
| Stochastic Oscillator | 12.48 | 51.57 |
Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.